MedTech Global Insights Podcast By Ran Chen cover art

MedTech Global Insights

MedTech Global Insights

By: Ran Chen
Listen for free

What's next in the future of health? Welcome to MedTech Global Insights, the podcast dedicated to uncovering the most disruptive technologies and brilliant minds in the medical field. Whether you're an industry professional, investor, or simply curious, subscribe for your dose of cutting-edge information and expert commentary.Copyright 2026 Ran Chen Biological Sciences Economics Science
Episodes
  • Pure Global: Malaysia's MedTech Handshake, ASEAN's New Shortcut

    Pure Global: Malaysia's MedTech Handshake, ASEAN's New Shortcut
    Mar 31 2026
    In this episode of MedTech Global Insights, we unpack the most significant regulatory shift in Southeast Asia this year. The costly and time-consuming process of seeking individual device approvals in each country is being replaced by a powerful new trend: regulatory reliance. We dive into the new pilot program between Malaysia and Thailand that is creating an expedited pathway for market access. Imagine your company just spent two years and a significant budget getting your device approved in one country. Now you face the same mountain in the neighboring market. What if there was a way to use your existing approval to cut the next timeline in half? This is the reality that new ASEAN reliance programs are creating, but navigating them requires insider knowledge. This week's insights: - What exactly is the new Malaysia-Thailand regulatory reliance pilot program? - How does this "shortcut" actually accelerate your market entry process? - Which specific device classes are most likely to benefit? - Is this a one-off deal or part of a larger strategic trend in Southeast Asia? - How can approvals from the US or EU be leveraged in this new framework? - What are the hidden risks or documentation requirements for using these pathways? - How does this fundamentally change the strategy for MedTech expansion into Asia? - Which country's approval now offers the best "gateway" to the broader ASEAN region? For a deeper conversation on building your global strategy, contact us at info@pureglobal.com or visit https://pureglobal.com/. You can also explore our FREE AI tools and medical device database at https://pureglobal.ai/.
    Show more Show less
    2 mins
  • Pure Global: EU's MedTech Shortage & The New Supply Rules

    Pure Global: EU's MedTech Shortage & The New Supply Rules
    Mar 30 2026
    The European Union is taking decisive action to combat the critical shortage of medical devices, a problem that has plagued its healthcare systems since the rollout of MDR. This episode unpacks the European Commission's new proposal for a mandatory six-month notification period for discontinuing devices, and what it means for manufacturers. This isn't just another form to fill out. it's a fundamental shift in market responsibility that directly impacts product lifecycle management, supply chain forecasting, and your competitive position. We explore the strategic challenges and opportunities this new era of mandatory transparency creates for MedTech companies operating in the EU. A French manufacturer of a critical diagnostic assay decides to discontinue the product due to low margins and high MDR compliance costs. Their plan was to quietly phase it out within three months. Suddenly, they are faced with the new six-month mandatory notification rule, forcing them to continue production at a loss, manage difficult conversations with distributors, and alert competitors to their exit strategy far earlier than intended, creating a significant strategic dilemma. Key Takeaways: - What triggers the mandatory six-month shortage notification requirement in the EU? - How does this new rule change the financial calculation for discontinuing a legacy product? - What specific information must manufacturers now provide to competent authorities? - How can you turn supply chain transparency into a competitive advantage in the EU market? - What are the legal and commercial risks of failing to comply with this new proposal? - How should this rule affect your product portfolio and end-of-life strategies? - Does this new EU rule align with or diverge from supply notification rules in the US or other markets? Contact us at info@pureglobal.com or visit https://pureglobal.com/ or visit https://pureglobal.ai/ for FREE AI tools and free medical device database.
    Show more Show less
    2 mins
  • Pure Global: Germany's AI Device Sudden Compliance Shock.

    Pure Global: Germany's AI Device Sudden Compliance Shock.
    Mar 29 2026
    This week, MedTech Global Insights explores the seismic shift in European regulations for AI-powered medical devices. A major EU Notified Body has dropped a new, mandatory cybersecurity guidance document, sending shockwaves through the industry by demanding retroactive compliance. We unpack what this means for manufacturers, from agile startups to global giants. We explore the stringent new requirements for a Software Bill of Materials (SBOM) and penetration testing, and the immediate compliance scramble that is turning a regulatory update into a high-stakes business challenge. Consider this case: a promising MedTech company's leading AI diagnostic software, already on the market, is suddenly facing delisting. This is the reality for innovators who now must prove end-to-end digital safety based on rules that didn't exist when they got their approval. Their pain is a warning for all that market access is not guaranteed to last. Key Takeaways: - Why is a Software Bill of Materials suddenly a deal-breaker for EU market access? - What are the three biggest cybersecurity vulnerabilities that regulators are targeting now? - Could your existing CE mark be invalidated by a post-market guidance update? - What are the hidden operational costs of this new compliance scramble? - How does this shift the definition of market-readiness for all software-based medical devices? - Is this new regulation a barrier to entry, or an opportunity for prepared firms? For more information, contact us at info@pureglobal.com or visit https://pureglobal.com/. You can also visit https://pureglobal.ai/ for FREE AI tools and a free medical device database.
    Show more Show less
    2 mins
No reviews yet